Maja de Jonge

Maja de Jonge is a Researcher at the Erasmus MC, part of the Medical Oncology department at Erasmus University Rotterdam. Her work focuses on understanding pharmacological mechanisms in cancer treatment and improving patient outcomes through advanced therapeutic strategies and clinical trial methodologies.

Her research interests include the study of immune checkpoint inhibitors (ICIs), adverse event management in oncology, pharmacokinetics of cancer drugs, and optimizing decision-making processes in palliative care. She also investigates the progression of brain metastases in melanoma patients and evaluates novel drug candidates like BI 905677 in phase I trials.

Maja has contributed to over 150 research outputs, including peer-reviewed articles, reviews, and chapters. Her work emphasizes translating pharmacological insights into clinical practice while addressing ethical and practical challenges in patient care. She collaborates internationally to advance neuro-oncology and immunotherapy research.

With 4 supervised works, Maja mentors research initiatives but specific student names are not listed. Her research integrates interdisciplinary approaches, combining oncology with critical care medicine and neuroimaging to improve treatment efficacy and patient quality of life.